Scots-Knight Denise
- SEC CIK
- 0001297000
No open-market purchases or sales filed in the past year.
Current role at each company
- ELAN Elanco Animal Health IncDirectoras of May 26, 2026
- MREO Mereo BioPharma Group plcChief Executive Officeras of Feb 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Scots-Knight Denise as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MREO Mereo BioPharma Group plc
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 (view filing) | Sep 12-13 | 4 days | Scots-Knight DeniseChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −88.7K | $4.30 | −$381.3K | −9.9%808.9K after | 2 lots |
| Jun 27, 2024 (view filing) | Jun 25-26 | 2 days | Scots-Knight DeniseChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −133.0K | $3.48 | −$463.0K | −15.8%709.5K after | 2 lots |